Advances in Polyhydroxyalkanoate Nanocarriers for Effective Drug Delivery: An Overview and Challenges
Polyhydroxyalkanoates (PHAs) are natural polymers produced under specific conditions by certain organisms, primarily bacteria, as a source of energy. These up-and-coming bioplastics are an undeniable asset in enhancing the effectiveness of drug delivery systems, which demand characteristics like non...
Main Authors: | Priyanka Prakash, Wing-Hin Lee, Ching-Yee Loo, Hau Seung Jeremy Wong, Thaigarajan Parumasivam |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/12/1/175 |
Similar Items
-
Current situation and challenges of polyhydroxyalkanoates-derived nanocarriers for cancer therapy
by: Xiao-Yun Huang, et al.
Published: (2024-12-01) -
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
by: Kailash C. Petkar, et al.
Published: (2021-03-01) -
A mini-review of Nanocarriers in Drug Delivery Systems
by: Mahsa Mazdaei, et al.
Published: (2022-05-01) -
Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications
by: Yi-Qun Yu, et al.
Published: (2021-03-01) -
An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
by: Francesca Susa, et al.
Published: (2024-06-01)